These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 10918574

  • 1. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 2. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 3. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH.
    Virology; 1995 Oct 01; 212(2):490-9. PubMed ID: 7571419
    [Abstract] [Full Text] [Related]

  • 4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 5. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 15; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 7. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.
    Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L.
    Cancer Res; 2007 Jan 01; 67(1):75-84. PubMed ID: 17210685
    [Abstract] [Full Text] [Related]

  • 9. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX, Papkoff J, Sarkar NH.
    Virology; 1999 Mar 01; 255(1):138-49. PubMed ID: 10049829
    [Abstract] [Full Text] [Related]

  • 10. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J.
    Oncogene; 2004 Aug 12; 23(36):6047-55. PubMed ID: 15208658
    [Abstract] [Full Text] [Related]

  • 11. Mouse mammary tumor virus derived from wild mice does not target Notch-4 protooncogene for the development of mammary tumors in inbred mice.
    Sarkar NH.
    Virology; 2009 May 25; 388(1):121-7. PubMed ID: 19329137
    [Abstract] [Full Text] [Related]

  • 12. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.
    MacArthur CA, Shankar DB, Shackleford GM.
    J Virol; 1995 Apr 25; 69(4):2501-7. PubMed ID: 7884899
    [Abstract] [Full Text] [Related]

  • 13. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N, Baines D, Moore R, Brookes S, Dickson C, Peters G.
    Virology; 1993 May 25; 194(1):157-65. PubMed ID: 8386870
    [Abstract] [Full Text] [Related]

  • 14. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI, Leder P.
    Oncogene; 1996 Dec 19; 13(12):2507-15. PubMed ID: 9000125
    [Abstract] [Full Text] [Related]

  • 15. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration.
    Takenaka T, Saga S, Miyaishi O, Imai M, Yokoi T, Lu J, Wajjwalku W, Kusakabe M, Taguchi O, Matsuyama M.
    Nagoya J Med Sci; 1991 Mar 01; 53(1-4):9-21. PubMed ID: 1666666
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor alpha and mouse models of human breast cancer.
    Humphreys RC, Hennighausen L.
    Oncogene; 2000 Feb 21; 19(8):1085-91. PubMed ID: 10713694
    [Abstract] [Full Text] [Related]

  • 19. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
    Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M.
    Nat Genet; 2000 Jul 21; 25(3):329-32. PubMed ID: 10888884
    [Abstract] [Full Text] [Related]

  • 20. Gene expression array analyses predict increased proto-oncogene expression in MMTV induced mammary tumors.
    Popken-Harris P, Kirchhof N, Harrison B, Harris LF.
    Virus Res; 2006 Aug 21; 119(2):177-86. PubMed ID: 16469401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.